# Aminophylline and Cognitive Function After Sevoflurane Anaesthesia

> **NCT01022151** · PHASE2 · COMPLETED · sponsor: **King Faisal University** · enrollment: 180 (actual)

## Conditions studied

- Anaesthesia

## Interventions

- **DRUG:** Placebo [group P]
- **DRUG:** 0.2 mL/kg of aminophylline 10 mg/mL [group A2]
- **DRUG:** 0.2 mL/kg of aminophylline 15 mg/mL [group A3]
- **DRUG:** 0.2 mL/kg of aminophylline 20 mg/mL [group A4]
- **DRUG:** 0.2 mL/kg of aminophylline 25 mg/mL [group A5]
- **DRUG:** Doxapram 1 mg/kg [group D]

## Key facts

- **NCT ID:** NCT01022151
- **Lead sponsor:** King Faisal University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-07
- **Final completion:** 2010-08
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2010-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01022151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01022151, "Aminophylline and Cognitive Function After Sevoflurane Anaesthesia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01022151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*